Eledon Pharmaceuticals (ELDN) Earnings Date & Reports

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ELDN is expected to report earnings to fall 53.33% to -15 cents per share on August 06

Eledon Pharmaceuticals ELDN Stock Earnings Reports

Q2'26

Est.

$-0.15

Q1'26

Missed

by $0.15

Q4'25

Beat

by $0.10

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.09

The last earnings report on May 13 showed earnings per share of -33 cents, missing the estimate of -18 cents. With 1.33M shares outstanding, the current market capitalization sits at 293.31M.

View a ticker or compare two or three

Compare

ELDN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ELDN